LUPINUpdated 1 Sept 2026, 2:54

Lupin Limited

LUPINUpdated 1 Sept 2026, 2:54

Market Cap

₹1,00,068Cr.

Current Price

₹2,188

High / Low

₹2,530/1,875

Stock P/E

15.1

ROE21.2%

ROCE26.2%

Book Value₹659

Face Value₹2.00

Dividend Yield0.82%

About

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	94	146	113	179	120	120	105	84	87	96	122	129
Inventory Days	211	214	232	229	216	216	236	260	230	216	239	251
Days Payable	126	126	161	150	118	136	104	110	119	148	146	189
Cash Conversion Cycle	179	234	184	258	218	199	237	234	197	163	215	191
Working Capital Days	115	169	127	219	171	154	146	124	110	116	153	135
ROCE %	40%	36%	30%	11%	16%	10%	9%	-1%	3%	14%	22%	26%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 2:54

LUPIN LIMITED (LUPIN) financials — quarterly results, P&L, cash flow, balance sheet, shareholding